Edimer Pharmaceuticals (United States)

Edimer Pharmaceuticals (United States)

Open Access statistics for Edimer Pharmaceuticals (United States), United States, covering academic research published from 2002 to 2020.

Open Access statistics for Edimer Pharmaceuticals (United States), United States, covering academic research published from 2002 to 2020. Read More.


Open Access Percentage

60%


Total
Publications

84


Total Open
Publications

50


Total
Citations

5.9K


Open Access
Percentage

60%


Total
Publications

84


Total Open
Publications

50


Total
Citations

5.9K

Website

download

Breakdown

10% 36% 14% 40%

Publisher Open

10%

Both

36%

Other Platform Open

14%

Closed

40%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2002200320042005200620072008200920102011201220132014201520162017201820192020

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

024681012141618Total Publications
2002200320042005200620072008200920102011201220132014201520162017201820192020

Open

Closed

Publisher Open

21%OA Journal

OA Journal 21%

8

Hybrid 47%

18

No Guarantees 32%

12

Other Platform Open

Domain 90%

38

Institution 29%

12

Public 29%

12

Other Internet 10%

4

Preprint 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
38
Europe PMC
Domain
32
Semantic Scholar
Public
12
University of Edinburgh - Edinburgh Research Explorer
Institution
7
Université de Lausanne - SERVAL
Institution
5
University of California - eScholarship University of California
Institution
3
University of Oxford - Oxford University Research Archive (ORA)
Institution
2
Le Centre pour la Communication Scientifique Directe - HAL - Université Paris Descartes
Institution
2
Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg - OPUS FAU - Online-Publikationssystem der Friedrich-Alexander-Universität Erlangen-Nürnberg
Other Internet
2
Figshare
Public
2
1 / 2

Data updated 8 December 2024

Share

Share

Share